IMUX Immunic Inc

USD 0.96 +0.02 ( +2.03%)
Icon

Immunic Inc (IMUX) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.96

+0.02 (+2.03%)

USD 0.09B

0.47M

USD 5.50(+474.71%)

N/A

Icon

IMUX

Immunic Inc (USD)
COMMON STOCK | NSD
USD 0.96
+0.02 ( +2.03%)
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.09B

N/A

USD 0.96

Immunic Inc (IMUX) Stock Forecast

Show ratings and price targets of :
USD 5.50
(+474.71%)

Based on the Immunic Inc stock forecast from 2 analysts, the average analyst target price for Immunic Inc is USD 5.50 over the next 12 months. Immunic Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Immunic Inc is Bearish, which is based on 1 positive signals and 4 negative signals. At the last closing, Immunic Inc’s stock price was USD 0.96. Immunic Inc’s stock price has changed by -2.36% over the past week, -10.56% over the past month and -17.50% over the last year.

No recent analyst target price found for Immunic Inc
No recent average analyst rating found for Immunic Inc

Company Overview Immunic Inc

Immunic, Inc., a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany. Its lead development program is IMU-838, which is in Phase 3 clinical trial, for ...Read More

https://imux.com

1200 Avenue of the Americas, New York, NY, United States, 10036

85

December

USD

USA

Adjusted Closing Price for Immunic Inc (IMUX)

Loading...

Unadjusted Closing Price for Immunic Inc (IMUX)

Loading...

Share Trading Volume for Immunic Inc Shares

Loading...

Compare Performance of Immunic Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for IMUX

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Immunic Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc +9.38 (+2.07%) USD118.90B 32.57 220.35

Frequently Asked Questions About Immunic Inc (IMUX) Stock

Based on ratings from 2 analysts Immunic Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 2 buy, sell and hold ratings.

Unfortunately we do not have enough data on IMUX's stock to indicate if its a good dividend stock.

Based on targets from 2 analysts, the average taret price for IMUX is USD 5.50 over the next 12 months. The maximum analyst target price is USD 6 while the minimum anlayst target price is USD 5.

Unfortunately we do not have enough data on IMUX's stock to indicate if its overvalued.

The last closing price of IMUX's stock was USD 0.96.

The most recent market capitalization for IMUX is USD 0.09B.

Based on targets from 2 analysts, the average taret price for IMUX is projected at USD 5.50 over the next 12 months. This means that IMUX's stock price may go up by +474.71% over the next 12 months.

We can't find any ETFs which contains Immunic Inc's stock.

As per our most recent records Immunic Inc has 85 Employees.

Immunic Inc's registered address is 1200 Avenue of the Americas, New York, NY, United States, 10036. You can get more information about it from Immunic Inc's website at https://imux.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Frequently Asked Questions About Immunic Inc (IMUX) Stock

Based on ratings from 2 analysts Immunic Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 2 buy, sell and hold ratings.

Unfortunately we do not have enough data on IMUX's stock to indicate if its a good dividend stock.

Based on targets from 2 analysts, the average taret price for IMUX is USD 5.50 over the next 12 months. The maximum analyst target price is USD 6 while the minimum anlayst target price is USD 5.

Unfortunately we do not have enough data on IMUX's stock to indicate if its overvalued.

The last closing price of IMUX's stock was USD 0.96.

The most recent market capitalization for IMUX is USD 0.09B.

Based on targets from 2 analysts, the average taret price for IMUX is projected at USD 5.50 over the next 12 months. This means that IMUX's stock price may go up by +474.71% over the next 12 months.

We can't find any ETFs which contains Immunic Inc's stock.

As per our most recent records Immunic Inc has 85 Employees.

Immunic Inc's registered address is 1200 Avenue of the Americas, New York, NY, United States, 10036. You can get more information about it from Immunic Inc's website at https://imux.com.
Loading...